John T. Schindler, MD; Katherine M. Spooner, MD; Catherine F. Decker, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Schindler JT, Spooner KM, Decker CF. “Buffalo Humps” Associated with Protease Inhibitors. Ann Intern Med. 1999;130:242. doi: 10.7326/0003-4819-130-3-199902020-00015
Download citation file:
Published: Ann Intern Med. 1999;130(3):242.
Although few reports have discussed the development of cervical neck masses in HIV-infected patients receiving only nucleoside analogues (1, 2), it was not until the recent addition of protease inhibitors to the antiretroviral regimen that “buffalo humps” and atypical fat redistribution became more evident to the clinician (3). It has been suggested, but not proven, that there is a relation between the use of these agents in combination with nucleoside and non-nucleoside analogues and the development of these body habitus changes.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only